Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1067-1075

  Walus, Lee R ^a,c   Pardridge, William M ^d   Starzyk, Ruth M ^c   Friden, Phillip M ^b,c  

^a BIOGEN   (United States)

^b Periodontix Inc   (United States)

^c ALKERMES INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; RS CD4; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; DRUG CONJUGATION; DRUG RECEPTOR BINDING; DRUG TRANSPORT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS CELL INTERACTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BLOOD-BRAIN BARRIER; BRAIN; CERCOPITHECUS AETHIOPS; HUMANS; MALE; MICE; RATS; RECEPTORS, TRANSFERRIN; RECOMBINANT PROTEINS;

EID: 0030431699     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. BERGER, E. A., FUERST, T. R. ANDMOSS, B.: A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S A 85: 2357-2361, 1988.
2. BICKEL, U., YOSHIKAWA, T., LANDAW, E. M., FAULL, K. F. ANDPARDRIDGE, W. M.: Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90: 2618-2622, 1993.
3. BOURNE, G. H.: The Rhesus Monkey, vol. 1, pp. 6-10, Academic Press, New York, 1975.
4. CARLSSON, J., DREVIN, H AND AXÉN, R.: Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem. J. 173: 723-737, 1978.
5. CHAMOW, S. M., KOGAN, T P., PEERS, D. H., HASTINGS, R. C., BYRN, R. A. AND ASHKENAZI, A.: Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent J. Biol. Chem. 267: 15916-15922, 1992.
6. CHEN, L. L., ROSA, J. J., TURNER, S. ANDPEPINSKY, R. B.: Production of multimeric forms of CD4 through a sugar-based cross-linking strategy. J Biol. Chem. 266: 18237-18243, 1991.
7. DEEN, K. C., MCDOUGAL, J. S., INACKER, R., FOLENA-WASSERMAN, G., ARTHOS, J., ROSENBERG, J., MADDON, P. J., AXEL, R. ANDSWEET, R. W.: A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (Lond.) 331: 82-84, 1988.
8. DUNCAN, R. J. S., WESTON, P. D. ANDWRIGGLESWORTH, R.: A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132: 68-73, 1983.
9. ELLMAN, G. L.: Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77, 1959.
10. EY, P. L., PROWSE, S. J. ANDJENKIN, C. R.: Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15: 429-436, 1978.
11. FISHER, R. A., BERTONIS, J. M., MEIER, W., JOHNSON, V. A., COSTOPOULOS, D. S., LIU, T., TIZARD, R., WALKER, B. D., HIRSCH, M. S., SCHOOLEY, R. T. ANDFLAVELL, R. A.: HIV infection is blocked in vitro by recombinant soluble CD4. Nature 33: 76-78, 1988.
12. FRIDEN, P. M., WALUS, L. R., MUSSO, G. F., TAYLOR, M. A., MALFROY, B. AND STARZYK, R. M.: Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 88:4771-4775, 1991.
13. FRIDEN, P. M., WALUS, L. R., WATSON, P., DOCTROW, S. R., KOZARICH, J. W., BACKMAN, C., BERGMAN, H., HOFFER, B., BLOOM, F. ANDGRANHOLM, A.-C.: Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science (Wash. DC) 259: 373-377, 1993.
14. GHETIE, V., TILL, M. A , GHETIE, M.-A., TUCKER, T., PORTER, J., PATZER, E. J., RICHARDSON, J. A., UHR, J. W. ANDVITETTA, E. S.: Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers. Bioconjugate Chem. 1: 24-31, 1990a.
15. GHETIE, V., TILL, M. A., GHETIE, M.-A., UHR, J. W. ANDVITETTA, E. S.: Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chain. J. Immunol. Methods 126: 135-141, 1990b.
16. GIBALDI, M. ANDPERRIER, D.: Pharmacokinetics, Marcel Dekker, Inc., New York, p. 215, 1982.
17. GOSWAMI, K. K., MILLER, R. F., HARRISON, M. J., HAMEL, D. J., DANIELS, R. S. AND TEDDER, R. S.: Expression of HIV-1 in the cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 5: 797-803, 1991.
18. HO, D. D., ROTA, T. R., SCHOOLEY, R. T., KAPLAN, J. C., ALLAN, J. D., GROOPMAN, J. E , RESNICK, L., FELSENSTEIN, D., ANDREWS, C. A. ANDHIRSCH, M. S.: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to acquired immunodeficiency syndrome. N. Engl. J. Med. 313: 1493-1497, 1985.
19. HUSSEY, R. E., RICHARDSON, N. E., KOWALSKI, M., BROWN, N. R., CHANG, H.-C., SILICIANO R. F., DORFMAN, T., WALKER, B., SODROSKI, J. ANDREINHERZ, E. L.: A soluble GD4 protein selectively inhibits HIV replication and syncytium formation. Nature (Lond.) 331: 78-81, 1988.
20. IDZIOREK, T. ANDKLATZMANN, D.: Construction of CD4-based chimeric molecules by chemical cross-linking. AIDS Res. Hum. Reteroviruses 7: 529-536, 1991.
21. JEFFERIES, W. A., BRANDON, M. R., HUNT, S. V., WILLIAMS, A. F., GATTER, K. C. AND MASON, D. Y.: Transferrin receptor on endothelium of brain capillaries. Nature (Lond.) 312: 162-163, 1984.
22. JEFFERIES, W. A., BRANDON, M. R., WILLIAMS, A. F. ANDHUNT, S. V.: Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. Immunology 54: 333-341, 1985.
23. KORDOWER, J. H , MUFSON, E. J., GRANHOLM, A-C., HOFFER, B. ANDFRIDEN, P. M.: Delivery of trophic factors to the primate brain. Exp. Neurol 124: 21-30, 1993.
24. 3H]propionate: use in detecting and analyzing monoclonal antibodies. Methods Enzymol. 121: 670-678, 1986.
25. LAEMMILI, U. K.: Cleavage of structural proteins during: the assembly of the head of bacteriophage T4. Nature (Lond.) 227: 680-685, 1970
26. PARDRIDGE, W. M., BUCIAK, J. L. ANDFRIDEN, P. M.: Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 259: 66-70, 1991.
27. PARDRIDGE, W. M., BUCIAK, J. L. ANDYOSHIKAWA, T.: Transport of recombinant CD4 through the rat blood-brain barrier in vivo. J. Pharmacol. Exp. Ther. 261: 1175-1180, 1992.
28. PARDRIDGE, W. M., KANG, Y.-S., BUCIAK, J. L. ANDYANG, J.: Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm. Res. 12: 807-816, 1995.
29. RODWELL, J. D., ALVAREZ, V. L., LEE, C., LOPES, A. D., GORES, J. W. F., KING, H. D., POWSNER, H. J. ANDMCKEARN, T. J.: Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. Proc. Natl. Acad. Sci. U.S.A. 83: 2632-2636, 1986.
30. SMITH, D. H., BYRN, R. A., MARSTERS, S. A., GREGORY, T., GROOPMAN, 'J. E. AND CAPON, D. J.: Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science (Wash. DC) 238: 1704-1707, 1987.
31. STEIN, B. S., GOUDA, S. D., LIFSON, J. D., PENHALLOW, R. C., BENSCH, K. G. AND ENGLEMAN, E. G.: pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49: 659-668, 1987.
32. TRAUNECKER, A., LÜKE, W. ANDKARJALAINEN, K.: Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature (Lond.) 331: 84-86, 1988.
33. TRIGUERO, D., BUCIAK, J. L. ANDPARDRIDGE, W. M.: Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate. J. Pharmacol. Exp. Ther. 258: 186-192, 1991.
34. TRIGUERO, D., BUCIAK, J. L. ANDPARDRIDGE, W. M.: Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J. Neurochem. 54: 1882-1888, 1990.
35. VASEUX, R.: AIDS encephalopathy and tropism of HIV for brain monocytes/ macrophages and microglial cells. Pathobiology 59: 214-218, 1991.
36. WHITE, S., TAETLE, R., SELIGMAN, P. A., RUTHERFORD, M AND TROWBRIBGE, I. S.: Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res. 50: 6295-6301, 1990.
37. YOSHIKAWA, T. ANDPARDRIDGE, W. M.: Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. J. Pharmacol. Exp. Ther. 263: 897-903, 1992.
38. ZARA, J. J., WOOD, R. D., BOON, P., KIM, C.-H., POMATO, N., BREDEHORST, R. AND VOGEL, C.-W.: A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates. Anal. Biochem. 194: 156-162, 1991.